PCN207 COST COMPARISON OF ADVERSE EVENT MANAGEMENT WITH...

PCN207 COST COMPARISON OF ADVERSE EVENT MANAGEMENT WITH POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS OR CHEMOTHERAPY IN GBRCA-MUTATED, HER2-NEGATIVE ADVANCED BREAST CANCER (ABC): A US AND GERMAN HEALTHCARE PERSPECTIVE

McCrea, C., MacDonald, D., Hettle, R., McLaurin, K., Specht, A., Merens, C., Wynne, T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.403
Date:
November, 2019
File:
PDF, 321 KB
english, 2019
Conversion to is in progress
Conversion to is failed